Featured by Bezinga: Health Care PE Is ‘No Longer An Easy Source Of Returns'

Featured by Bezinga: Health Care PE Is ‘No Longer An Easy Source Of Returns'

October 8, 2026
October 8, 2026

Share

Rob Larson

Managing Director

This article was originally featured by Bezinga and was written by Caroline Ryan.

Health care private equity is attracting billions of dollars from institutional investors even as limited partners become more selective about where they put their money and the industry’s ownership model faces growing regulatory scrutiny.


Health care PE managers raised $16.2 billion across 11 fund closes in the first half of 2026, according to PitchBook’s H1 2026 Healthcare Funds Report. This represents more than 90% of the $17.4 billion raised during all of 2025 and gave health care its largest-ever share of overall private equity fundraising, at 6.1%.


But the headline number masks a growing concentration of capital. Blackstone Life Sciences VI raised $6.3 billion, while Patient Square Capital II closed with $4.4 billion, meaning the two funds accounted for roughly two-thirds of health care PE capital raised in the first half.

Rob Larson, managing director at Grant Thornton Stax, told Benzinga that slower distributions have left LPs with fewer dollars to recycle into new funds, pushing them toward managers where they have the most conviction.


"When capital is constrained, an LP may prefer to make a larger commitment to a manager it has backed successfully through several cycles rather than spread that capital across lots of unproven managers," Larson said.

Rob Larson
Rob Larson

Managing Director

The concentration comes as health care PE’s recent performance has become less differentiated from the broader market.


PitchBook found that health care PE funds from the 2021-2023 vintages generated a 10.2% pooled IRR, compared with 12% for broader private equity. Earlier health care vintages had significantly outperformed the broader market.


Larson said health care remains attractive because of an aging population, rising utilization and opportunities to improve productivity, but "health care exposure by itself is no longer an investment thesis."

Bigger Funds, Fewer Easy Deals

The fundraising boom also raises a question about whether large health care managers can find enough attractive assets to deploy the capital they are raising.


Larson said there is not necessarily a shortage of health care businesses, but there is a shortage of large assets available at attractive valuations that can absorb sizable checks while still producing strong returns.


"As a fund gets larger, it gravitates toward larger companies where there are fewer assets and where you’re more often competing with other well-capitalized sponsors and strategic buyers," he said.


That could make deployment discipline increasingly important as fund sizes grow.

Regulatory Risk Enters the Equation

The fundraising strength comes as private equity’s role in health care faces greater political scrutiny.


Sen. Elizabeth Warren and Rep. Alexandria Ocasio-Cortez introduced legislation last month that would seek to prohibit private equity firms, insurers and other for-profit corporations from owning or controlling physician practices. The bill targets management services organizations and "friendly" or "captive" physician arrangements.


More than 82% of physicians were employed by hospitals or corporate entities as of January 2026, while corporate entities owned 33.2% of physician practices, according to research from the Physicians Advocacy Institute and Avalere Health.


Larson said regulatory changes have become a consistent underwriting consideration for investors.


"It has become a consistent underwriting consideration," Larson said. "Investors are asking not only, ‘Is this structure legal today?’ but also, ‘How could the rules change during our ownership period, and if they do would it break the business model?’"

He added that increased scrutiny doesn’t mean private capital will leave physician practices, but that winning models increasingly need to show value creation without compromising clinical independence or simply extracting more economics from the health care system.

Read more here Click here to read more

Read More

Stax Sell-side: Orbus Investment From Norwest Equity Partners
November 18, 2026
Grant Thornton Stax supported Orbus, a provider of visual communications solutions for in-person experiences, on its recent investment from Norwest Equity Partners. Read more here.
AI Is Everywhere in Public Safety Tech. What Will Separate the Winners?
By Chen Liu • November 13, 2026
Following the 2026 International Association of Chiefs of Police (IACP) Conference, Chen Liu shares five key takeaways on what will distinguish the leading providers. Read the full list here.
Grant Thornton Advisors Completes Acquisition of CBIZ
November 3, 2026
Grant Thornton Advisors LLC, New Mountain Capital, and CBIZ, Inc. today announced that Grant Thornton Advisors completed its acquisition of CBIZ. Read the full announcement here.
5 Key Takeaways from the Goodwin Pharma Services Symposium
By Jordan Abrams • October 30, 2026
Following the Goodwin Pharma Services Symposium, Jordan Abrams shares five key takeaways on the investment landscape for pharma services. Read his full list here.
Featured by ION Analytics: Private equity pays up for scale amid youth-enrichment platform scarcity
By Luke Scheibel • October 21, 2026
Luke Scheibel was interviewed by ION Analytics, where he shared his perspective on PE's rising interest in youth sports and the evolving investment considerations around them. Read more.
Paul Edwards & Robert Lytle Named Top PE Consultants & Leaders 2026
By Paul Edwards & Robert Lytle • October 21, 2026
Grant Thornton Stax is pleased to announce the naming of both Paul Edwards and Robert Lytle to The Consulting Report's Top Private Equity Consultants and Leaders of 2026. Read more here.
Show More